A practical guide to personalizing breast cancer screening, covering risk assessment, timing, frequency, and imaging strategy choices.
Key Takeaways
- No randomized trial has compared annual versus biennial screening using mortality as primary endpoint
- Personalized breast cancer screening decisions can improve early detection and treatment success
- In extremely dense breasts, adding MRI after a negative mammogram halved interval cancer rates